InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 17.55
-0.15 (-0.85%)
Sep 26, 2025, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 34.40 billion as of September 26, 2025. Its market cap has increased by 213.66% in one year.
Market Cap
34.40B
Enterprise Value
28.37B
Revenue
1.45B
Ranking
n/a
PE Ratio
n/a
Stock Price
17.55
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 34.40B, an increase of 180.13%. That is a compound annual growth rate of 20.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 34.40B | 172.26% |
| Dec 31, 2024 | 12.63B | -7.63% |
| Dec 29, 2023 | 13.68B | -44.57% |
| Dec 30, 2022 | 24.68B | 7.55% |
| Dec 31, 2021 | 22.95B | 32.04% |
| Dec 31, 2020 | 17.38B | 41.53% |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 279.26B |
| Hansoh Pharmaceutical Group Company | 210.92B |
| JD Health International | 206.50B |
| Innovent Biologics | 159.71B |
| WuXi Biologics | 158.73B |
| Sino Biopharmaceutical | 142.12B |
| Akeso | 122.24B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |